Whitelab Genomics Analysis: $10M Raised

Whitelab Genomics utilizes AI and biological data to enhance drug development in genomic medicine, focusing on the safety and efficacy of therapeutic candidates.

• WhiteLab Genomics has raised $10 million in funding.
• The funding round was led by investors including:
  • Alven Capital
  • Bpifrance
  • Eurazeo
  • Kima Ventures